Jay V. DePasse

2.0k total citations
36 papers, 1.5k citations indexed

About

Jay V. DePasse is a scholar working on Epidemiology, Modeling and Simulation and Health. According to data from OpenAlex, Jay V. DePasse has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 11 papers in Modeling and Simulation and 10 papers in Health. Recurrent topics in Jay V. DePasse's work include Influenza Virus Research Studies (23 papers), COVID-19 epidemiological studies (11 papers) and Vaccine Coverage and Hesitancy (10 papers). Jay V. DePasse is often cited by papers focused on Influenza Virus Research Studies (23 papers), COVID-19 epidemiological studies (11 papers) and Vaccine Coverage and Hesitancy (10 papers). Jay V. DePasse collaborates with scholars based in United States, South Korea and Canada. Jay V. DePasse's co-authors include Elodie Ghedin, Rebecca Halpin, Edward C. Holmes, Adam Fitch, David Spiro, Shawn T. Brown, Claudio L. Afonso, Xinsheng Zhang, Naomi Sengamalay and Appolinaire Djikeng and has published in prestigious journals such as Nature Communications, Nature Genetics and Clinical Infectious Diseases.

In The Last Decade

Jay V. DePasse

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay V. DePasse United States 17 833 482 250 233 200 36 1.5k
Gytis Dudas United States 18 626 0.8× 633 1.3× 283 1.1× 160 0.7× 156 0.8× 29 1.4k
Kimihito Ito Japan 24 877 1.1× 815 1.7× 360 1.4× 188 0.8× 146 0.7× 80 1.9k
Luiz Max Carvalho Brazil 13 541 0.6× 1.0k 2.1× 261 1.0× 210 0.9× 168 0.8× 30 1.9k
Thomas Tran Australia 22 824 1.0× 1.0k 2.1× 273 1.1× 91 0.4× 95 0.5× 49 1.9k
Bram Vrancken Belgium 21 526 0.6× 800 1.7× 238 1.0× 135 0.6× 61 0.3× 58 1.6k
Jayna Raghwani United Kingdom 15 1.6k 1.9× 817 1.7× 431 1.7× 679 2.9× 150 0.8× 26 2.3k
Yuki Furuse Japan 22 768 0.9× 655 1.4× 469 1.9× 124 0.5× 254 1.3× 71 1.7k
Nicolás Berthet France 25 633 0.8× 762 1.6× 532 2.1× 94 0.4× 76 0.4× 87 1.8k
Andreas Handel United States 29 957 1.1× 1.0k 2.1× 318 1.3× 185 0.8× 600 3.0× 89 2.5k
Bettina Bankamp United States 26 1.6k 1.9× 1.2k 2.4× 261 1.0× 100 0.4× 104 0.5× 45 2.2k

Countries citing papers authored by Jay V. DePasse

Since Specialization
Citations

This map shows the geographic impact of Jay V. DePasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay V. DePasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay V. DePasse more than expected).

Fields of papers citing papers by Jay V. DePasse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay V. DePasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay V. DePasse. The network helps show where Jay V. DePasse may publish in the future.

Co-authorship network of co-authors of Jay V. DePasse

This figure shows the co-authorship network connecting the top 25 collaborators of Jay V. DePasse. A scholar is included among the top collaborators of Jay V. DePasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay V. DePasse. Jay V. DePasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Kenneth J., Mary Patricia Nowalk, Jonathan M. Raviotta, et al.. (2019). Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis. American Journal of Preventive Medicine. 56(4). e135–e141. 3 indexed citations
2.
DePasse, Jay V., Mary Patricia Nowalk, Kenneth J. Smith, et al.. (2019). Exploring the potential public health benefits of universal influenza vaccine. Human Vaccines & Immunotherapeutics. 15(12). 2919–2926. 2 indexed citations
3.
Wateska, Angela R., Mary Patricia Nowalk, Jay V. DePasse, et al.. (2018). Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults. Innovation in Aging. 2(3). igy035–igy035. 3 indexed citations
4.
Wedlock, Patrick T., Sheryl S. Siegmund, Jay V. DePasse, et al.. (2018). Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries. Vaccine. 36(39). 5879–5885. 6 indexed citations
5.
Bartsch, Sarah M., Michael Taitel, Jay V. DePasse, et al.. (2018). Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic. Vaccine. 36(46). 7054–7063. 29 indexed citations
6.
Wedlock, Patrick T., Jim Leonard, Joel Welling, et al.. (2018). The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains. Vaccine. 37(4). 645–651. 10 indexed citations
7.
Raviotta, Jonathan M., Kenneth J. Smith, Jay V. DePasse, et al.. (2017). Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults. Vaccine. 35(42). 5708–5713. 13 indexed citations
8.
Smith, Kenneth J., Mary Patricia Nowalk, Angela R. Wateska, et al.. (2017). Potential Consequences of Not Using Live Attenuated Influenza Vaccine. American Journal of Preventive Medicine. 53(4). 500–503. 1 indexed citations
9.
Smith, Kenneth J., Jonathan M. Raviotta, Jay V. DePasse, et al.. (2016). Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2–8 Years in the U.S.. American Journal of Preventive Medicine. 50(5). 600–608. 10 indexed citations
10.
Hogan, William R., Michael M. Wagner, Mathias Brochhausen, et al.. (2016). The Apollo Structured Vocabulary: an OWL2 ontology of phenomena in infectious disease epidemiology and population biology for use in epidemic simulation. Journal of Biomedical Semantics. 7(1). 50–50. 9 indexed citations
11.
Shim, Eunha, Shawn T. Brown, Jay V. DePasse, et al.. (2016). Cost Effectiveness of Influenza Vaccine for U.S. Children. American Journal of Preventive Medicine. 51(3). 309–317. 12 indexed citations
12.
Poon, Leo L. M., Timothy Song, Roni Rosenfeld, et al.. (2016). Quantifying influenza virus diversity and transmission in humans. Nature Genetics. 48(2). 195–200. 118 indexed citations
13.
DePasse, Jay V., Roni Rosenfeld, Elodie Ghedin, et al.. (2014). A large-scale immuno-epidemiological simulation of influenza A epidemics. BMC Public Health. 14(1). 1019–1019. 32 indexed citations
14.
Saira, Kazima, Xudong Lin, Jay V. DePasse, et al.. (2013). Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus. UCL Discovery (University College London). 2 indexed citations
15.
Grefenstette, John J., Shawn T. Brown, Roni Rosenfeld, et al.. (2013). FRED (A Framework for Reconstructing Epidemic Dynamics): an open-source software system for modeling infectious diseases and control strategies using census-based populations. BMC Public Health. 13(1). 940–940. 154 indexed citations
16.
Kerr, Peter J., Elodie Ghedin, Jay V. DePasse, et al.. (2012). Evolutionary History and Attenuation of Myxoma Virus on Two Continents. PLoS Pathogens. 8(10). e1002950–e1002950. 79 indexed citations
17.
Ghedin, Elodie, Jennifer Laplante, Jay V. DePasse, et al.. (2010). Deep Sequencing Reveals Mixed Infection with 2009 Pandemic Influenza A (H1N1) Virus Strains and the Emergence of Oseltamivir Resistance. The Journal of Infectious Diseases. 203(2). 168–174. 89 indexed citations
18.
Ghedin, Elodie, Tiruneh Hailemariam, Jay V. DePasse, et al.. (2009). Brugia malayi Gene Expression in Response to the Targeting of the Wolbachia Endosymbiont by Tetracycline Treatment. PLoS neglected tropical diseases. 3(10). e525–e525. 38 indexed citations
19.
Djikeng, Appolinaire, Rebecca Halpin, Ryan Kuzmickas, et al.. (2008). Viral genome sequencing by random priming methods. BMC Genomics. 9(1). 5–5. 274 indexed citations
20.
Liu, Canhui, Ana de Oliveira, Tarig B. Higazi, et al.. (2007). Sequences necessary for trans-splicing in transiently transfected Brugia malayi. Molecular and Biochemical Parasitology. 156(1). 62–73. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gytis Dudas Breakdown of academic impact, for papers by Kimihito Ito Breakdown of academic impact, for papers by Luiz Max Carvalho Breakdown of academic impact, for papers by Thomas Tran Breakdown of academic impact, for papers by Bram Vrancken Breakdown of academic impact, for papers by Jayna Raghwani Breakdown of academic impact, for papers by Yuki Furuse Breakdown of academic impact, for papers by Nicolás Berthet Breakdown of academic impact, for papers by Andreas Handel Breakdown of academic impact, for papers by Bettina Bankamp
Rankless by CCL
2026